 It was patented in 1931.The drug is marketed as a combination of (Paracetamol-Caffeine-Propyphenazone) tablets in effective treatment for primary headache disorder.It is marketed globally by Bayer, and in India as "Saridon" by Piramal, and "Dart" by Juggat Pharma.